Lisi Group (FII) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
12 Jun, 2025Executive summary
Achieved organic growth over 10% for the third consecutive year, with revenue reaching a record €1,794.0M, up 10.0% year-over-year, driven by strong aeronautics market momentum.
EBIT rose to €115.0M (+26.9%), net profit increased 49.2% to €56.0M, and EPS grew 48.2% to €1.23 compared to 2023.
Operating Free Cash Flow was positive across all divisions at €57.7M, and net debt was reduced by €12.6M post share buyback.
Financial highlights
EBITDA reached €211.8M (+18.9% year-over-year), with EBITDA margin improving to 11.8% (+0.9 pts).
Operating cash flow was €170.0M (9.5% of sales), financing higher CAPEX of €100.4M (5.6% of sales).
Net debt at €488.5M (2.3x EBITDA), net debt-to-equity ratio improved to 48.6% from 53.4%.
Dividend proposed at €0.39 per share, up from €0.31.
Outlook and guidance
Sustained aeronautics growth expected to offset potential automotive sector volatility.
Targeting continued improvement in key financial indicators, assuming stable macroeconomic conditions.
Aeronautics division enters 2025 with strong order visibility and revised sales price base; automotive faces continued H1 2025 slowdown but is positioned for adaptation.
Latest events from Lisi Group
- Record revenue, profit surge, and reduced debt driven by aerospace growth and medical division sale.FII
H2 202526 Feb 2026 - Strong 9.1% revenue growth driven by aerospace, with key portfolio shifts in medical and automotive.FII
Q3 2025 TU23 Oct 2025 - Record sales and EBIT growth in H1 2025, led by aerospace, with strong outlook confirmed.FII
H1 202528 Jul 2025 - Aerospace drives 8.6% sales growth, offsetting automotive decline and medical stabilization.FII
Q3 2024 TU13 Jun 2025 - Record sales and improved margins in H1 2024, led by strong aerospace performance.FII
H1 202413 Jun 2025 - Aerospace and medical growth drove Q1 sales up 8.3%, offsetting automotive decline.FII
Q1 2025 TU6 Jun 2025